LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.


Netscientific Plc

0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 70.00 12,058 08:00:22
Bid Price Offer Price High Price Low Price Open Price
68.00 72.00 71.50 70.00 70.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceutical Preparations 1.11 -2.39 -11.30 - 14.79
Last Trade Time Trade Type Trade Size Trade Price Currency
15:41:30 O 569 70.18 GBX

Netscientific (NSCI) Latest News

Netscientific (NSCI) Discussions and Chat

Netscientific Forums and Chat

Date Time Title Posts
02/6/202316:45NetScientific PLC5,466

Add a New Thread

Netscientific (NSCI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Netscientific (NSCI) Top Chat Posts

Top Posts
Posted at 31/5/2023 20:59 by kingston78
The market capitalisation of PDSB is US$298 million = GBP 238 million @ 4.4% holding = GBP 10.5 million share asset to NSCI, which has a market value of GBP 16 million.

In other words, roughly the remaining assets are valued at only GBP 5.5 million, some of which have potential to be blockbuster in their own right, given the opportunity and right connection and condition. The range of investment is diverse, which should increase the chance of success.

Market consensus has a strong buy for PDSB with a one year target of US$ 21 (currently US$ 9.68 today), let's say it may double in 12 months, meaning that it will be worth GBP 20 million to NSCI. That is more than the current market value of NSCI.

The fact that NSCI is languishing means that the directors and or advisors do not convince the right investors about its success stories. We are just small fish as individual private investors, and we need the big boys to invest in this company to push up the share price.

Posted at 31/5/2023 16:57 by blakieboy7
PDSB now up over 9 dollars, not that it's making FA difference to NSCI share price!! That's over 5.5% up so far
Posted at 29/5/2023 16:39 by kingston78
The average twelve-month price prediction for PDS Biotechnology is $17.00 with a high price target of $21.00 and a low price target of $12.00. Currently, it is at US$8.56.

There is tremendous upside for PDSB, so it will lift up the share price of NSCI if logics dictates. There is a disconnect between the two until maybe one day when PDSB is taken over, crystallising the gain in cash when the market wakes up that the cash amount to NSCI is more than the entire NSCI group.

Posted at 24/5/2023 16:56 by lazygun
sofant and immarsat collaboration.

surprised no commentaary on this today:

NetScientific PLC Sofant and Inmarsat announce joint development
24/05/2023 7:00am
RNS Non-Regulatory


NetScientific PLC

24 May 2023

Reach: 24 May 2023

NetScientific plc

("NetScientific" or the "Company")

Sofant Technologies and Inmarsat Government to develop Phased Array Antenna for Aircraft

NetScientific Plc (AIM: NSCI), investment and commercialisation group with an international portfolio of innovative life science, sustainability and technology companies, reports that its portfolio company, Sofant Technologies ("Sofant"), a leading innovator in advanced antenna technologies, and Inmarsat Government ("Inmarsat"), the leading provider of secure, global, mission-critical telecommunications to the US Government, have today announced a joint development aimed at revolutionising the communication capabilities of aircraft.

Together, Sofant and Inmarsat will collaborate on a state-of-the-art phased array antenna designed to enhance connectivity, reliability, and performance in airborne operations.

The collaboration will combine their respective expertise to develop an innovative solution that addresses the Government airborne users' growing demand for efficient, low-profile communication systems.

The new phased array antenna will leverage Sofant's core technology to produce a compact, lightweight, and low-power terminal, which will enable reliable, seamless high-speed global coverage on a wider range of aircraft through Inmarsat's Global Xpress (GX) network, the world's first and only high-throughput commercial wideband network available worldwide. This includes seamless switching on the GX commercial network 's global service beams and Inmarsat's high-capacity, global military Ka-band (Mil Ka) network 's steerable beams.

David Wither, CEO, Sofant Technologies, said:

"We are thrilled to partner with Inmarsat Government on this development program. By leveraging our leading-edge antenna technology, we aim to deliver a transformative solution that will redefine communication capabilities for airborne platforms. This collaboration aligns with our vision of revolutionizing connectivity in the aerospace industry and beyond. We are confident that our joint efforts will yield exceptional results."

Steve Gizinski, President, Inmarsat Government, said :

"We are dedicated to providing cutting-edge communication solutions that empower our customers to excel in their missions. Collaborating with Sofant Technologies allows us to push the boundaries of innovation further, and together, we will develop a phased array antenna that sets new industry standards. This collaboration represents a significant step forward in meeting the Government's growing demand for secure and reliable connectivity worldwide."

Dr Ilian Iliev, CEO of NetScientific, added:

"We gained exposure to the Sofant investment through our acquisition of EMV Capital and its portfolio, and since then NetScientific has supported investments through our capital light investment approach, combining direct and advised stakes. A key feature of our deep tech investment model is to encourage portfolio companies to work closely with global OEMs as a capital efficient way of growth, and to internationalise early. Hence, we are delighted with today's announcement, which is a significant milestone for Sofant. The development collaboration between Inmarsat and Sofant underscores their commitment to driving advancements in airborne communication technology."


For more information, please contact:


Ilian Iliev, CEO Via Belvedere Communications

WH Ireland (NOMAD, Financial Adviser and Broker)

Chris Fielding / Darshan Patel / Enzo Aliaj +44 (0)20 7220 1666
Belvedere Communications

John West / Llew Angus +44 (0) 203 008 6867


About NetScientific

NetScientific plc (AIM: NSCI) is an investment and commercialisation group with an international portfolio of innovative life science, sustainability and technology companies.

NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.

NetScientific differentiates itself by employing a capital-light investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.

NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

May 24, 2023 02:00 ET (06:00 GMT)

Posted at 24/5/2023 15:50 by kingston78
MMs are manipulating the share price by widening the spread.

Anyway, short term traders and sellers of NSCI shares do not understand the potential of this company. They may make a few bucks here and there, but will miss out big time when there is a quantum leap in gigantic scale when one or more of its portfolio companies float onto the stock market, which alone will be bigger than NSCI itself.

Posted at 09/5/2023 11:41 by kingston78
Rainbow Rare Earth has raised £7.2 million by private placement at a PREMIUM of 28% to its share price.

If there is strong support for a good investment case some investors are happy to pay at a premium. Put it another way, if those investors want to buy a large amount of shares in the open market they will push up the share price anyway.

I am waiting for the day when NSCI announces a significant gain by floating or disposing of one or more of its investments, the sums of which will be more than the entire capitalisation at its current share price. There will be a quantum leap that its share price will double or triple instantly.

Posted at 17/4/2023 10:45 by kingston78
On 7th June 2021 almost two years ago the share price spiked to an intra day high of 209 p.

Share prices go in cycle as nature intends, in wave form, often over-extended either to the upside or to the downside.

I have studied NSCI's share chart using different time scales. I am convinced that they are currently all bullish.

No one knows what the future holds, but I guess that current management is working on exit strategies in crystallising substantial gains on one or more of its portfolio companies.

Investors Chronicle suggests that a conservative valuation per share is more than 160 p. I will go further than that. All brokers in the US are rating a strong buy for PDSB with a target of US$20 in a year's time (now US$6.9 a share with a market cap US$212 million). NSCI holds 4.4% of PDSB (US$9.3 million currently). This element alone illustrates how the British stock market has under-values NSCI.

Posted at 29/12/2022 14:05 by kingston78
Everything in nature moves in wave form. The same applies to share price. Let me explain about NSCI's share chart below.
(1) The stochastic is ticking upwards (for about a month, now at 70% (maximum 100%);
(2) The momentum is ticking upwards, now at 18%;
(3) The MACD is ticking upwards, now at 1, which could move to 6. The signal line has not yet cut the normal line, but I believe that it will cross it. As soon as the signal line crosses upwards the price will propel higher (it tells you the price will go up but there is no indication of amount of the rise. This works on every share / company).

I will supplement point 3 above:
(4) Purely based on NCSI's historical chart, its rise and fall was about 50 p each cycle. The last base from which the current share price has risen is 60 p. When adding 50 p my projection is therefore 110 p price target on this run. This fits into the upper Bollinger Band of 134 p where 110 p will comfortably be achieved.

Do your own research.

Posted at 21/12/2022 11:52 by kingston78
I didn't have trading facility to buy American shares otherwise I would have invested in PDSB when its share price fell below US$4 several months ago. At that time, NSCI was at about the same price as now, and yet PDSB has since propelled from under US4 to about US$ 10. NSCI has hardly increased in value, so this does not make sense. Moreover, consensus of one year target price for PDSB has been trimmed from US$20 to US$17, with strong buy amongst American brokers.

In any case, I am absolutely convinced that the low share price is due to lack of promotion by the company officers and brokers rather than by market makers. Market makers buy and sell and they don't care whether the price is high or low. They make a turn at every trade. If investor demand is high the share price will go up and vice versa.

I am familiar with the corporate world. I believe that any one of its portfolio companies could be worth more as a standalone company than the current entire group of NSCI. NSCI ridiculously cheap at its current price. There were times when brokers talked of 200 p each. Even their conservative estimates now say that it is worth at least 120 p.

Posted at 14/11/2022 20:30 by blakieboy7
A lot about NSCI share price doesn't make sense
Netscientific share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230602 22:52:15